Clinical Trial: HL2351 CAPS Phase II Study

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: An Open Label, Single Arm Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of HL2351 in Patients With Cryopyrin Associated Periodic Syndromes

Brief Summary: This is an open label, single arm trial to evaluate the efficacy, safety, and pharmacokinetics of HL2351 in patients with cryopyrin associated periodic syndromes (CAPS).